(Sharecast News) - Shares in Angle plunged on Tuesday, after the AIM-listed biotech warned full-year revenues risked being "significantly" constrained.
The firm, a specialist in liquid biopsies used in oncology, said it had faced "multiple headwinds" during the first half.

In particular, it said customers in both the pharmaceutical and...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE